A report from the Australian Council of Superannuation Investors finds Life360’s Silicon Valley-based executive chair is the highest-paid chief executive on the ASX in 2024-25, taking home $47.7 million. Life360 is dual listed on the ASX and Nasdaq and the family-tracking app’s global footprint feeds into its US-style remuneration structure.
The next two slots are also held by US-based bosses at dual-listed groups, the chief executive of sleep device maker ResMed at $35.2 million and News Corporation’s leader at $33.6 million.
Pay dominance does not stop with that trio. US-based leaders fill five of the top 10 places when ranked by take-home pay among ASX-listed company chiefs.
Alongside Life360, ResMed and News Corporation, the report names the head of Neuren Pharmaceuticals on $21.7 million and the chief of gold miner Newmont on $13.73 million. Those figures land in an environment where pay for locally based top executives has barely grown in more than a decade.
There is now a structural tension between globalised remuneration practices and a domestic market where investors and governance groups have long pushed for restraint. Dual listings and US headquarters expose Australian boards to American benchmarks that tend to be higher and more aggressively performance-linked.
Super funds and governance bodies are using this pay league table to question whether ASX companies are importing more US-style inflation than Australian shareholders are comfortable with.
